Professional Documents
Culture Documents
The major components of neuritic plaques found in Alzheimer disease (AD) are
peptides known as amyloid beta-peptides (Aβ), which are derived from the
proteolytic cleavage of the amyloid precursor protein (APP). In vitro Aβ may undergo
a conformational transition from a soluble form to aggregated, fibrillary beta-sheet
structures, which seem to be neurotoxic. Alternatively, it has been suggested that an
alpha-helical form can be involved in a process of membrane poration, which would
then trigger cellular death.
Phospholipase A2 (PLA2) is a small lipolytic enzyme that releases fatty acids from the
second carbon group of glycerol. It is involved in a number of physiologically
important cellular processes, such as the liberation of arachidonic acid from
membrane phospholipids. It plays a pivotal role in the biosynthesis of prostaglandin
and other mediators of inflammation. PLA2 has four to seven disulphide bonds and
binds a calcium ion that is essential for activity. Within the active enzyme, the alpha
amino group is involved in a conserved hydrogen-bonding network linking the N-
terminal region to the active site. There are ample evidences supporting both the
upregulation as well as down regulation of AD by PLA2. The study of Interaction
between these two proteins will contribute significantly for the better understanding
of the cause of AD and its therapy.
In my study I will try to infer direct structural interactions for interacting protein pair
and will try to establish a correlation between them.